Diagnosis and treatment of infections caused by rapidly growing mycobacteria

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 5, 2008, Pages 577-588

  Colombo, Rhonda E ^a   Olivier, Kenneth N ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Diagnosis; Nontuberculous mycobacteria (NTM); Rapidly growing mycobacteria (RGM); Treatment

Indexed keywords

AMIKACIN; AZITHROMYCIN; CEFAZOLIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; IMIPENEM; LINEZOLID; MACROLIDE; MOXIFLOXACIN; PYRIDOXINE; SULFONAMIDE; TIGECYCLINE; TOBRAMYCIN;

ANEMIA; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISSEMINATED BACTERIAL INFECTION; DRUG DOSE TITRATION; GASTROINTESTINAL SYMPTOM; HUMAN; KERATITIS; LUNG INFECTION; LUNG SURGERY; LYMPHADENITIS; MONOTHERAPY; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM IMMUNOGENEM; MYCOBACTERIUM SMEGMATIS; NAUSEA; NONHUMAN; OSTEOMYELITIS; OTITIS MEDIA; OTOTOXICITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; VOMITING;

ANTI-BACTERIAL AGENTS; HUMANS; LUNG DISEASES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 53549098582     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0028-1085709     Document Type: Review

References (73)

1. Witebsky FG, Conville PS. Rapidly growing mycobacteria. In: Bordello PS, Murray PR, Funke G, eds. Topley and Wilson's Microbiology and Microbial Infections: Bacteriology Volume 2. London: Hodder Arnold; 2005:1236-1269
2. Tortoli E. The new mycobacteria: an update. FEMS Immunol Med Microbiol 2006;48:169-178
3. Euzeby JP. List of prokaryotic names with standing in nomenclature-genus Mycobacterium. Accessed May 16, 2008 at http://www.bacterio.cict.fr/m/ mycobacterium.html
4. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416
5. Herdman AV, Steele JC Jr. The new mycobacterial species: emerging or newly distinguished pathogens. Clin Lab Med 2004;24:651-690
6. Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996;9:177-215
7. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002;15:716-746
8. De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis 2006;42:1756-1763
9. Howard ST, Byrd TF. The rapidly growing mycobacteria: saprophytes and parasites. Microbes Infect 2000;2:1845-1853
10. Munayco CV, Grijalva CG, Culqui DR, et al. Outbreak of persistent cutaneous abscesses due to Mycobacterium chelonae after mesotherapy sessions, Lima, Peru. Rev Saude Publica 2008;42:146-149
11. Winthrop KL, Abrams M, Yakrus M, et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med 2002;346:1366-1371
12. Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol 1998;52:453-490
13. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;23:553-567
14. Esteban J, Martin-de-Hijas NZ, Fernandez AI, et al. Epidemiology of infections due to nonpigmented rapidly growing mycobacteria diagnosed in an urban area. Eur J Clin Microbiol Infect Dis 2008 May 6. [Epub ahead of print]
15. Martin-Casabona N, Bahrmand AR, Bennedsen J, et al. Non-tuberculous mycobacteria: patterns of isolation: a multicountry retrospective survey. Int J Tuberc Lung Dis 2004; 8:1186-1193
16. Han XY, De I, Jacobson KL. Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol 2007;128:612-621
17. Bodle EE, Cunningham JA, Della-Latta P, Schluger NW, Saiman L. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis 2008;14:390-396
18. Han XY. Seasonality of clinical isolation of rapidly growing mycobacteria. Epidemiol Infect 2008;136:1188-1191
19. Holland SM. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity. Immunol Res 2007;38:342-346
20. Ebert DL, Olivier K. Nontuberculous mycobacteria in cystic fibrosis. Infect Dis Clin North Am 2002;16:221-233
21. Iseman MD, Buchanan DL, Ackerson LM. Pectus excavatum and scoliosis: thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1991;144:914-916
22. Falkinham JO. The changing pattern of nontuberculous mycobacterial disease. Can J Infect Dis 2003;14:281-286
23. Somoskovi A, Hotaling JE, Fitzgerald M, et al. Lessons from a proficiency testing event for acid-fast microscopy. Chest 2001;120:250-257
24. Somoskovi A, Mester J, Hale YM, Parsons LM, Salfinger M. Laboratory diagnosis of nontuberculous mycobacteria. Clin Chest Med 2002;23:585-597
25. Bange FC, Bottger EC. Improved decontamination method for recovering mycobacteria from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2002;21:546-548
26. Daley P, Petrich A, May K, et al. Comparison of in-house and commercial 16S rRNA sequencing with high performance liquid chromatography and genotype AS and CM for identification of nontuberculous mycobacteria. Diagn Microbiol Infect Dis 2008;61:284-293
27. Zelazny AM, Calhoun LB, Shea YR, et al. Identification of Mycobacterium species by secA1 sequences. J Clin Microbiol 2005;43:1051-1058
28. Böddinghaus B, Rogall T, Flohr T, Blöcker H, Böttger EC. Detection and identification of mycobacteria by amplification of rRNA. J Clin Microbiol 1990;28:1751-1759
29. Telenti A, Marchesi F, Balz M, et al. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993;31:175-178
30. Plikaytis BB, Plikaytis BD, Yakrus MA, et al. Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol 1992;30:1815-1822
31. Steingrube VA, Gibson JL, Brown BA, Zhang Y, Wilson RA. PCR Amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol 1995;33:149-153
32. Cloud JL, Neal H, Rosenberry R, et al. Identification of Mycobacterium spp. By using a commercial 16S ribosomal DNA sequencing kit and additional sequencing libraries. J Clin Microbiol 2002;40:400-406
33. Ringuet H, Akoua-Koffi C, Honore S. hsp65 sequencing for identification of rapidly growing mycobacteria. J Clin Microbiol 1999;37:852-857
34. Roth A, Fischer M, Hamid ME, Michalke S, Ludwig W, Mauch H. Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. J Clin Microbiol 1998;36:139-147
35. Kim B, Lee S, Lyu M, et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol 1999;37:1714-1720
36. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: an analysis of 154 patients. Am Rev Respir Dis 1993;147:1271-1278
37. Chan ED, Kaminska AM, Gill W, et al. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages. Scand J Infect Dis 2007;39:690-696
38. Daley CL, Griffith DE. Pulmonary disease caused by rapidly growing mycobacteria. Clin Chest Med 2002;23:623-632
39. Shelton BG, Flanders WD, Morris GK. Mycobacterium sp. as a possible cause of hypersensitivity pneumonitis in machine workers. Emerg Infect Dis 1999;5:270-273
40. Adekambi T, Berger P, Raoult D, Drancourt M. rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov. Mycobacterium phocaicum sp. nov and Mycobacterium aubagnense sp nov. Int J Syst Evol Microbiol 2006;56:133-143
41. Viana-Niero C, Lima KV, Lopes JL, et al. Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparascopic surgeries and cosmetic procedures. J Clin Microbiol 2008;46:850-855
42. Olivier KN, Weber DJ, Wallace RJ Jr, et al. Nontuberculous mycobacteria, I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828-834
43. Hadjiliadis D, Adlakha A, Prakash U. Rapidly growing mycobacterial lung infection in association with esophageal disorders. Mayo Clin Proc 1999;74:45-51
44. Park S, Suh GY, Chung MP, et al. Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens. Respir Med 2008;102:437-442
45. Cullen AR, Cannon CL, Mark EJ, Colin AA. Mycobacterium abscessus infection in cystic fibrosis: colonization or infection? Am J Respir Crit Care Med 2000;161:641-645
46. Boxerbaum B. Isolation of rapidly growing mycobacteria in patients with cystic fibrosis. J Pediatr 1980;96:689-691
47. Jacobson K, Libshitz H, Whimbey E, Rolston K, Abi-Said D, Raad I. Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients. Eur J Clin Microbiol Infect Dis 1998;17:615-621
48. Han D, Lee KS, Koh W, Yi CA, Kim TA, Kwon OJ. Radiographic and CT findings of nontuberculous mycobacterial pulmonary infection caused by Mycobacterium abscessus. AJR Am J Roentgenol 2003;181:513-517
49. Hazelton TR, Newell JD, Cook JL, et al. CT finding in 14 patients with Mycobacterium chelonae pulmonary infection. AJR Am J Roentgenol 2000;175:413-416
50. Woods GL, Bergmann JS, Witebsky FG, et al. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J Clin Microbiol 1999;37:1676-1682
51. Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ Jr. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother 2005;55:170-177
52. Nash KA, Andini N, Zhang Y, Brown-Elliott BA, Wallace RJ Jr. Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother 2006;50:3476-3478
53. Wallace RJ Jr, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocydine, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 2002;46:3164-3167
54. Wallace RJ Jr, Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 2001; 45:764-767
55. Wallace RJ Jr, Meir A, Brown BA, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996;40:1676-1681
56. Davis KK, Kao PN, Jacobs SS, Ruoss SJ. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. BMC Pulm Med 2007;7:2
57. Stein GE, Craig WA. Tigecycline: a critical analysis. Clin Infect Dis 2006;43:518-524
58. Smith MB, Hardin WD, Dressel DA, et al. Predicting outcomes following pulmonary resection in cystic fibrosis patients. J Pediatr Surg 1991;26:655-659
59. Taylor JL, Palmer SM. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant 2006;25:985-988
60. Fairhurst RM, Kubak BM, Shpiner RB, Levine MS, Pegues DA, Ardehali A. Mycobacterium abscessus empyema in a lung transplant recipient. J Heart Lung Transplant 2002;21:391-394
61. Sanguinetti M, Ardito F, Fiscarelli E, et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 2001;39:816-819
62. Chernenko SM, Humar A, Hutcheon M, et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience 2006. J Heart Lung Transplant 2006;25:1447-1455
63. Lamy B, Marchandin H, Hamitouche K, Laurent F. Mycobacterium setense sp. nov., a Mycobacterium fortuitum-group organism isolated from a patient with soft tissue infection and osteitis. Int J Syst Evol Microbiol 2008;58:486-490
64. Talati NJ, Rouphael N, Kuppalli K, Franco-Paredes C. Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet Infect Dis 2008;8:390-398
65. Uslan DZ, Kowalski TJ, Wenenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol 2006;142:1287-1292
66. Galil K, Miller LA, Yakrus MA, et al. Abscesses due to Mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis 1999;5:681-687
67. Wallace RJ Jr, Musser JM, Hull SI, et al. Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery. J Infect Dis 1989;159:708-716
68. John T, Velotta E. Nontuberculous (atypical) mycobacterial keratitis after LASIK: current status and clinical implications. Cornea 2005;24:245-255
69. Hawkins C, Qi C, Warren J, Stosor V. Catheter related bloodstream infections caused by rapidly growing nontuberculous mycobacteria: a case series including rare species. Diagn Microbiol Infect Dis 2008;61:187-191
70. Chetchotisakd P, Mootsikapun P, Anunnatsiri S, et al. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin Infect Dis 2000;30:29-34
71. Holland SM, Eisenstein EM, Kuhns DB, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: a preliminary report. N Engl J Med 1994;330:1348-1355
72. Daines BS, Vroman DT, Sandoval HP, Steed LL, Solomon KD. Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keromileusis. J Cataract Refract Surg 2003;29:1014-1018
73. Rodriguez B, Holzinger KA, Le LH, Winkle RK, Allen RD. Mycobacterium chelonae keratitis after laser-assisted subepithelial keratectomy. J Cataract Refract Surg 2006;32:1059-1061